Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

U.S. Public Sees Benefit In Device Advances, Views Industry With Skepticism

This article was originally published in The Gray Sheet

Executive Summary

The American public's view that the fruits of the medical device industry save and improve lives is dampened by the perceived insincerity of companies vis-a -vis patients, results of a public opinion poll show.

You may also be interested in...



Rep. Ramstad Nearly Ready To Unveil Y2K Version Of Medicare Legislation

Rep. Jim Ramstad, co-chair of the House Medical Technology Caucus, currently is finalizing the "Medicare Patient Access to Technology Act" for reintroduction after the Easter recess, most likely in the first two weeks of May, staffers to the Minnesota Republican report.

Abbott Readying Vildagliptin ER In India Amid Price Competition

Abbott is developing an extended release version of vildagliptin in India, adding a new dimension to the market dynamics for the DPP-4 inhibitor, which has seen a key patent expire. Sustained release vildagliptin products from Wockhardt and Synokem also appear to be in the works.
UsernamePublicRestriction

Register

MT013207

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel